Valuation: GRAIL, Inc.

Market Cap 3.37B 2.92B 2.74B 2.5B 4.7B 322B 4.78B 32.07B 12.57B 161B 12.66B 12.38B 537B P/E 2026 *
-7.52x
P/E 2027 * -7.1x
Enterprise Value 2.76B 2.39B 2.24B 2.04B 3.85B 263B 3.91B 26.28B 10.3B 132B 10.37B 10.15B 440B EV / Sales 2026 *
15.3x
EV / Sales 2027 * 13.4x
Free-Float
94.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week+3.82%
Current month+10.09%
1 month+4.83%
3 months+23.21%
6 months-24.82%
Current year-11.81%
1 week 60.76
Extreme 60.76
76.44
1 month 60.76
Extreme 60.76
76.44
Current year 41.5
Extreme 41.5
118.84
1 year 29.95
Extreme 29.95
118.84
3 years 12.33
Extreme 12.33
118.84
5 years 12.33
Extreme 12.33
118.84
10 years 12.33
Extreme 12.33
118.84
Manager TitleAgeSince
Chief Executive Officer 62 2026-05-31
Director of Finance/CFO 47 2021-10-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2026-03-11
Director/Board Member 58 2024-06-20
Director/Board Member 66 2024-06-20
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Director

276 0.0006%
7/15/26 Free

Chairman

427 0.0010%
7/15/26 Free

Director

268 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+3.82%+130.90% - 3.37B
-0.72%+3.41%+6.32%+16.27% 49.54B
-0.69%+6.25%+492.36%+585.40% 44.06B
+0.08%+11.23%+23.99%+81.74% 40.85B
+0.76%+6.85%+35.40%+10.92% 40.14B
+4.73%+13.29%+27.76%+54.22% 34.17B
-0.41%+4.08% - - 16.78B
+0.51%+5.29%+34.62%+126.87% 16.9B
-0.20%+1.57%+5.49%+21.35% 14B
+1.81%+20.45%+89.35%+31.49% 13.46B
Average +0.67%+262.57%+94.02%+116.03% 27.33B
Weighted average by Cap. +0.57%+294.09%+107.84%+138.65%

Financials

2026 *2027 *
Net sales 181M 157M 147M 134M 252M 17.26B 256M 1.72B 674M 8.64B 679M 665M 28.82B 227M 197M 184M 168M 316M 21.63B 321M 2.16B 845M 10.83B 852M 833M 36.12B
Net income -427M -370M -347M -316M -595M -40.76B -605M -4.07B -1.59B -20.4B -1.6B -1.57B -68.07B -466M -404M -378M -345M -649M -44.46B -660M -4.43B -1.74B -22.26B -1.75B -1.71B -74.25B
Net Debt -609M -528M -494M -451M -849M -58.1B -863M -5.79B -2.27B -29.08B -2.29B -2.24B -97.02B -331M -287M -269M -245M -461M -31.59B -469M -3.15B -1.23B -15.81B -1.24B -1.22B -52.75B
Logo GRAIL, Inc.
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.
Employees
910
Date Price Change Volume
26-08-11 US$75.48 +0.86% 575,766
26-08-10 US$74.84 +7.71% 1,394,654
26-08-07 US$69.48 +9.59% 1,643,880
26-08-06 US$63.40 -14.53% 1,882,132
26-08-05 US$74.18 +2.04% 514,191
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
75.48USD
Average target price
72.38USD
Spread / Average Target
-4.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GRAL Stock